新诊断的古典霍奇金淋巴瘤:在新治疗时代优化治疗结果
1Division of Blood Disorders, Rutgers Cancer Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Hematological oncology
|June 15, 2025
概括
经典霍奇金淋巴瘤 (cHL) 治疗的进步,包括向疗法和适应反应的策略,已经显著提高了所有阶段和年龄组的生存率. 未来的研究重点是针对个性化治疗计划的生物标志物.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床试验 临床试验
背景情况:
- 经典霍奇金淋巴瘤 (cHL) 的治疗已经显著发展.
- 改进的预测和适应响应的策略推动了进步.
研究的目的:
- 审查前线治疗新诊断的古典霍奇金淋巴瘤的最新进展.
- 突出新型向药物和临床试验的影响.
主要方法:
- 标志性随机临床试验的审查.
- 对早期疾病的基于PET的响应调整研究的分析.
- 布伦图西马布韦多丁和检查点抑制剂在晚期cHL中的整合.
主要成果:
- 针对早期cHL的精细治疗方法,平衡疗效和长期后果.
- 在使用新药的高级阶段cHL中,无进展生存率超过90%.
- 通过量身定制的方法和向治疗,改善了老年cHL患者的治疗结果.
结论:
- 新型向性药物和适应反应的策略已经改变了cHL治疗.
- 未来的研究应该专注于个性化治疗的生物标志物和预测模型.
- 持续的创新有望提高cHL患者的生存率和生活质量.
关键词:
霍奇金淋巴瘤是一种霍奇金淋巴瘤.癌症 癌症 癌症 癌症 癌症化学疗法 化疗 化疗免疫疗法 免疫疗法个性化治疗是个性化的治疗.晚期影响 后期影响结果就是结果.预测建模预测建模预后 预后 预后人们的生活质量.辐射辐射辐射辐射的辐射有针对性的治疗.治疗治疗治疗治疗治疗治疗更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.0K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
1.1K
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
